6月12日 - ** 医疗技术公司Conmed CNMD.N盘前下跌2.6%，至55.5美元，此前Needham将其评级从 "买入 "下调至 "持有"。
** 券商称，该公司的长期增长率下降，意味着每股收益增长放缓，债务水平限制了其扩大新的增长动力或回购股票的能力。
** Needham 补充说，它认为 CNMD 的交易价格较同行有很大折扣，但该公司的市盈率接近同行，因此下调了其评级
** 六位分析师的平均评级为 "持有"；市盈率中位数为61美元--数据由LSEG编制
** 截至上次收盘，CNMD年累计下跌16.8%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.